Eli Lilly's Q3 adjusted EPS of $7.48 tops estimates; profit reaches $6.45 billion
Eli Lilly reported adjusted earnings of $7.48 per share for the third quarter. Revenue was $24.4 billion. Both figures exceeded expectations. The company guided full-year earnings to a range of $35 to $36 per share.
